Cori Clinical Raises $4M Seed

Cori Clinical, an AI-powered platform for clinical trial design, has raised $4 million in a seed funding round. The company provides a workspace that centralizes clinical trial data to streamline study planning and regulatory submissions.

Investors

This round was led by Breega, with additional participation from Enzo, Heartfelt, Together Ventures, and Bynd.

Cori Clinical Use of Funds

Cori Clinical plans to use the new capital to support product development and expand its delivery capacity. The funding will also support the growth of the company's clinical, engineering, and commercial teams, as well as the deepening of regulatory and clinical intelligence within the platform.

About Cori Clinical

Founded in 2026 by Jorn Jansen Schoonhoven and Patricio Fernández, Cori Clinical provides an AI workspace that enables teams to turn trial briefs into full protocols and operational plans. By consolidating internal knowledge with external regulatory data, the platform creates a living blueprint to reduce trial set-up costs and minimize avoidable protocol errors.

Funding Details

Company Website: https://cori-clinical.com

Company: Cori Clinical
Raised: $4M
Round: Seed
Funding Date: October 7, 2026
Lead Investor: Breega
Additional Investors: Enzo, Heartfelt, Together Ventures, Bynd
Software Category: Medtech
Source: https://tech.eu/2026/10/07/cori-clinical-secures-4m-seed-to-improve-clinical-trial-design-and-cut-delays/